Resultados de la búsqueda 381-390 of 8880 for Lithium toxicity

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

5. Radiología - Ensayos clínicos - Mayo Clinic

   * Is \[Ac225\]RTX-2358 tolerable or does it cause toxicities (medical problems) in patients. * What is the most tolerable dose of \[Ac225\]RTX-2358 * Does ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. ... toxicity. Patient demographics, adverse events, and comorbidities will ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...